Endocrinology is a branch of medicine that deals with the endocrine system, associated organs and the diseases and conditions that may arise, as well as the overall metabolic function of the body.
Featured Learning Zones
Cushing’s Syndrome is a rare disease which is the physiological consequence of an excess of cortisol, either released from an endocrine tumour or from exogenous sources. In this educational resource, you will discover the symptoms of Cushing's syndrome in adults and find a detailed description of the pathophysiology and its resultant impact on morbidity and mortality.
Endocrinology also deals with psychological and physical conditions associated with hormone changes due to disease or congenital defects in the endocrine system. This medical speciality focuses on the diagnosis and treatment of diabetes, cardiovascular metabolism as well as many rare diseases such as Cushing’s syndrome.
Related news and insights
Novo Nordisk has announced the submission of a label expansion application to the FDA for the existing marketing authorisation for Ozempic, a once-weekly glucagon-like peptide-1 (GLP-1) analogue, to introduce a new dose of 2.0 mg.
Lexicon Pharmaceuticals announced that it has received FDA regulatory feedback that the results of its SOLOIST and SCORED Phase III clinical studies of Zynquista (sotagliflozin) can support a new drug application (NDA) submission for an indication to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent visits for heart failure in adult patients with type 2 diabetes with either worsening heart failure or additional risk factors for heart failure.
Bayer announced that the FDA has accepted its New Drug Application (NDA) and granted Priority Review for finerenone to treat patients with chronic kidney disease (CKD) and type 2 diabetes (T2D).